Epigenetic aging prior to midlife is gaining interest as an intervenable period to address health and cognitive aging. Epigenetic changes may index DNA methylation aging rates, but methylation profiles may not be substitutable across tissues. We compared DNA methylation clocks and age acceleration in saliva, buffy coat (BC), and peripheral blood mononuclear cells (PBMC) collected in 91 individuals (7 unpaired, 20 siblings, 64 twins; 18 monozygotic (MZ), 14 dizygotic (DZ) pairs) from the Colorado Adoption/Twin Study of Lifespan behavioral development and cognitive aging (CATSLife1; Mean age = 30.90 years range = 28.07-41.13; 50.5% female). Across 15 DNA methylation clocks, chronological age and DNA methylation ages were moderately associated (mean Spearman correlations: r = 0.37, Saliva; r = 0.40, BC; r = 0.34, PBMC). In mixed-effects models, saliva showed higher DNA methylation ages (B = 3.77-19.72 years vs BC, p B = -0.06-0.39 years vs BC, p ≥ 0.436). The exception was the next-generation clock DunedinPace showing comparability (p = 0.486). Similar patterns were observed for age acceleration estimates. Altogether, MZ pairs (meta-analytic r = 0.49, 95%CI = 0.32,0.66) and DZ pairs (meta-analytic r = 0.38, 95%CI = 0.25,0.52) were moderately correlated (Spearman), but MZ pairs showed heterogeneity across tissues (p r = 0.33, SD = 0.25) than BC (mean r = 0.64, SD = 0.10) and PBMC (mean r = 0.49, SD = 0.18). Next-generation PCGrimAge and DunedinPace clocks showed consistent zygosity correlations across tissues, while multi-tissue clocks (e.g. ZhangQ) showed comparable MZ-DZ correlations. While saliva-based DNA methylation is not a direct substitute for blood-based DNA methylation, BC and PBMC show comparability; nevertheless, all tissue types may be appropriate for DNA methylation aging studies when compared within tissues.
Bruellman et al. (Wed,) studied this question.